BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Kruppel-like factor 10 (KLF10)

February 5, 2015 8:00 AM UTC

In vitro studies suggest a new KLF10 inhibitor could help improve the efficacy of cancer immunotherapy. The transcription factor KLF10 regulates conversion of T cells into T regulatory cells (Tregs) t...